Nielsen Survey Finds China Consumers Most Concerned About Drugs’ Credibility
This article was originally published in PharmAsia News
Executive Summary
According to a recent worldwide online survey jointly conducted by Nielsen Company and the Association of the European Self-Medication Industry, more than 30 percent of China consumers indicate they would self-medicate for minor ailments such as headache, cold and dyspepsia. They consider credibility, safety and effectiveness as the three most important criteria for OTC drugs. Nearly two-thirds of respondents prefer to take medicine only if they do not get well naturally after some time, while two percent say they never take medicine. Almost 70 percent of these two groups attribute their avoidance of medicine to the perception of drug toxicity. When selecting prescription drugs, close to half of China respondents said that a trustworthy brand is the most important factor. Such concern is also the highest in the global survey. (Click here for more - Chinese Language)
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.